Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Delta 2-N-Acetyl Cefixime | C18H17N5O8S2 | 495.49 | |||
| N,N-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide | N,N-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]; Bosentan impurity C; Bosentan USP Related Compound C | 1097263-60-9 | C52H52N10O10S2 | 1041.16 | N,N-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]; Bosentan impurity C; Bosent... |
| O-[2-(Acetylamino)-2-deoxy-alpha -D-galactopyranosyl]-L-threonine | 67315-18-8 | C12H22N2O8 | 322.31 | ||
| Ceftazidime Methyl Ester (Contains ~10% triethylammonium iodide) | 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[[2-(methoxy)-1,1-dimethyl-2-oxoethoxy]imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium Inner Salt; Ceftazidime EP Impurity H | 1354396-23-8 | C23H24N6O7S2 | 560.6 | 1-[[(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[[2-(methoxy)-1,1-dimethyl-2-oxoethoxy]imino]acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oc... |
| S-(3-Acetylanisole) Captopril | (S)-1-((S)-3-((2-(3-Methoxyphenyl)-2-oxoethyl)thio)-2-methylpropanoyl)pyrrolidine-2-carboxylic acid | C18H23NO5S | 365.44 | (S)-1-((S)-3-((2-(3-Methoxyphenyl)-2-oxoethyl)thio)-2-methylpropanoyl)pyrrolidine-2-carboxylic acid | |
| E-Ceftazidime | (6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Ceftazidime Impurity B | 97148-38-4 | C22H22N6O7S2 | 546.58 | (6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct... |
| S-(3-Acetylanisole-d3) Captopril | (S)-1-((S)-3-((2-(3-(Methoxy-d3)phenyl)-2-oxoethyl)thio)-2-methylpropanoyl)pyrrolidine-2-carboxylic acid-d3 | C18H20D3NO17S | 560.46 | (S)-1-((S)-3-((2-(3-(Methoxy-d3)phenyl)-2-oxoethyl)thio)-2-methylpropanoyl)pyrrolidine-2-carboxylic acid-d3 | |
| N,N-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide-d4 | N,N-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]-d4; Bosentan impurity C-d4 | C52H48D4N10O10S2 | 1045.18 | N,N-[1,2-ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide]-d4; Bosentan impurity C-d4
... | |
| Alpha-Acetyl-3,4-dichlorobenzeneacetonitrile | 2-(3,4-Dichlorophenyl)acetoacetonitrile | 6097-31-0 | C10H7Cl2NO | 228.07 | 2-(3,4-Dichlorophenyl)acetoacetonitrile |
| 1-(3-O-Acetyl-2-deoxy-beta-D-erythro-pentofuranosyl)-4-amino-1,3,5-triazin-2(1H)-one | 1254186-97-4 | C10H14N4O5 | 270.24 |
Page 389 of 10017